30 participants
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-19
- Start Date:
- 2023-02-28
- Completion:
- 2025-03-01
Conditions
- Adenocarcinoma of the Stomach
- Adenocarcinoma of Esophagogastric Junction
- HER2-positive Gastric Cancer
Interventions
- DRUG
No Results Yet